Utility of midpoint imaging in patients receiving peptide receptor radionuclide therapy (PRRT) for advanced progressive midgut neuroendocrine tumors (NET)

被引:0
|
作者
Norman, A. [1 ]
Wee, C. [1 ]
Hobday, T. [1 ]
Kendi, A. [1 ]
Johnson, G. [1 ]
Thorpe, M. [1 ]
Lunn, B. [1 ]
Bach, C. [1 ]
Eiring, R. [1 ]
Halfdanarson, T. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
midpoint imaging; prrt; clinical decision making;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
K25
引用
收藏
页码:192 / 192
页数:1
相关论文
共 50 条
  • [21] Reduced efficacy of repeated peptide receptor radionuclide therapy (PRRT) in progressive gastroenteropancreatic neuroendocrine tumours (GEP-NET)?
    Schnurr, J.
    Reimold, M.
    Dittmann, H.
    Kupferschlaeger, J.
    Bares, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S396 - S396
  • [22] Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Low Grade Neuroendocrine Tumors (mNETs)
    Naraev, Boris G.
    Sharma, Nancy
    Engelman, Eric S.
    Bushnell, David L., Jr.
    O'Dorisio, Thomas M.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2012, 41 (02) : 347 - 348
  • [23] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [24] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [25] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [26] Efficacy of the Chronic Lanreotide Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP/NET) after Peptide Receptor Radionuclide Therapy (PRRT)
    Szalus, N.
    Kaminski, G.
    Podgajny, Z.
    Dziuk, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 137 - 137
  • [27] Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Shimamura, Takeshi
    Takano, Shoko
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Ichikawa, Yasushi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (09) : 727 - 739
  • [28] Surgery after Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Bertani, E.
    Chiappa, A.
    Fazio, N.
    Grana, C.
    Bodei, L.
    Falconi, M.
    Ravizza, D.
    Spada, F.
    Andreoni, B.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 285 - 285
  • [29] Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry
    Hernando Cubero, J.
    Lago, N. Martinez
    Mitjavila, M.
    Garcia-Burillo, A.
    Pubul, V.
    Bello, P.
    Cano, J. M.
    Llana, B.
    Castellon, M.
    Rodeno, E.
    Pineiro, A.
    Soldevilla, C.
    Nevares, M.
    Aller, J.
    Anido Herranz, U.
    Carnero Lopez, B.
    Nogareda, Z.
    Garcia Alvarez, A.
    Jimenez Fonseca, P.
    Capdevila Castillon, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S756 - S756
  • [30] Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
    Camus, Baptiste
    Cottereau, Anne-Segolene
    Palmieri, Lola-Jade
    Dermine, Solene
    Tenenbaum, Florence
    Brezault, Catherine
    Coriat, Romain
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 18